Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalized endothelial cell activation

Critical Care Medicine

Volumn 26, Issue 2, 1998, Pages 296-300

  McGill, Sandra N ^a   Ahmed, Najma A ^b   Christou, Nicolas V ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Critical illness; Endothelium; Enzyme linked immunosorbent assay; Factor VIII; Immunohistochemistry; Platelet aggregation; Sepsis; Systemic inflammatory response syndrome; Tumor necrosis factor; von Willebrand factor

Indexed keywords

RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DEGRANULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; SEPSIS; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CRITICAL ILLNESS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRADERMAL; MALE; MICROCIRCULATION; MIDDLE AGED; RECOMBINANT PROTEINS; SKIN; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; VON WILLEBRAND FACTOR;

EID: 0031916636     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199802000-00031     Document Type: Article

References (51)

1. Ahmed NA, Christou NV, Meakins JL: The systemic inflammatory response syndrome and the critically ill surgical patient. Current Opinion in Critical Care 1995; 1:290-305
2. Ahmed NA, Christou NV: Interactions between immune cells and the endothelium. Shock 1996; 6(Suppl):S1-S4
3. Cotran RS, Pober JS: Cytokine-endothelial interactions in inflammation, immunity and vascular injury. J Am Sci Nephrol 1990; 1:225-235
4. Bradley JR, Wilks D, Rubenstein D: The vascular endothelium in septic shock. J Infection 1994; 28:1-10
5. Tracey K: Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 1991; 35:123-128
6. Carswell EA, Old LJ, Kassel RL, et al: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72:3666-3670
7. Bevilacqua MP, Pober JS, Majeau GR, et al: Recombinant TNF induces procoagulant activity in cultured human vascular endothelial cells: characterization and comparison of the actions of IL-1. Proc Natl Acad Sci U S A 1986; 83:4533-4537
8. Nawroth P, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740-745
9. Schleef RR, Bevilacqua MP, Sawdey M, et al: Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988; 263:5797-5803
10. Nawroth PP, Handley DA, Esmon CT, et al: Interleukin-1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A 1986; 83:3460-3464
11. Hoyer LW: The Factor VIII complex: structure and function. Blood 1981; 58:1-10
12. Jaffe EA, Hoyer LW, Nachman RL: Synthesis of anti-haemophillic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52:2745-2756
13. Bowie EJW, Solberg LA, Fass DN, et al: Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest 1986; 78:26-30
14. Reinders JH, DeGroot PG, Gonsalves MD, et al: Isolation of a storage and secretory organelle containing von Willebrand protein from cultured human endothelial cells. Biochem Biophys Acta 1984; 804:361-369
15. Wagner DD, Olmsted JB, Marder VJ: Immunolocalization of von Willebrand protein in Wiebel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95:355-360
16. Ewenstein BM, Warhol MJ, Handin RI, et al: Composition of the von Willebrand factor storage organelle (Wiebel-Palade body) isolated from cultured human endothelial cells. J Cell Biol 1987; 104:1423-1433
17. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent vWf multimers. Cell 1986; 46:185-190
18. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. J Clin Invest 1987; 79:600-608
19. Ribes JA, Francis CW, Wagner DD: Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest 1987; 79:117-123
20. Levine JD, Harlan JM, Harker LA, et al: Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 1982; 60:531-534
21. Tannenbaum SH, Rick ME, Shafer B, et al: Subendothelial matrix of cultured endothelial cells contains fully processed high molecular weight von Willebrand factor. J Lab Clin Med 1989; 113:372-378
22. Sporn LA, Marder VJ, Wagner DD: Von Willebrand factor released from Wiebel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 1987; 69:1531-1534
23. Moake JL, Turner NA, Stathopoulos NA, et al: Involvement of large von Willebrand factor (vWf) multimers and unusually large vWf forms from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 1986; 78:1456-1461
24. Moake JL, Turner NA, Stathopoulos NA, et al: Shear induced platelet aggregation can be mediated by vWf released from platelets, as well as exogenously large or unusually large vWf multimers, requires adenosine diphosphate and is resistant to aspirin. Blood 1988; 71:1366-1374
25. Kahaleh MB, Osborn I, LeRoy EC: Increased factor VIII/von Willebrand factor-antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med 1981; 94:482-484
26. Geggel RL, Carvalho CA, Hoyer LW, et al: von Willebrand factor abnormalities in primary pulmonary hypertension. Am Rev Respir Dis 1987; 135:294-299
27. Ambruso DR, Duranton DP, McIntosh RM, et al: Factor VIII and renal disease. Ann Intern Med 1977; 87:636-637
28. Giustolisi R, Musso R, Cacciola E, et al: Abnormal plasma levels of factor VIII/ von Willebrand factor complex in myocardial infarction-expression of acute phase reaction or index of vascular endothelium damage. Thromb Haemost 1984; 51:408-412
29. Lufkin EG, Fass DN, O'Fallon WM, Bowie EJW: Increased von Willebrand factor in diabetes mellitus. Metab Clin Exp 1979; 28:63-66
30. Rubin DB, Wiener-Kronish JP, Murray JF, et al: Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in non-pulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
31. Carvalho ACA, Bellman SM, Saullo VJ, et al: Altered factor VIII in acute respiratory failure. N Engl J Med 1982; 307:1113-1119
32. Sabharwal AK, Bajaj SP, Ameri A, et al: Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 1995; 151:758-767
33. Harlan JM, Harker LA, Striker GF, et al: Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 1983; 29:15-26
34. Schorer AE, Moldow CF, Rick ME: Interleukin-1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol 1987; 67:193-207
35. Giddings JC, Shall L: Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin-1. Thromb Res 1987; 47:259-267
36. 2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. J Immunol 1989; 142:3993-3999
37. Paleolog EM, Crossmann DC, McVey JH, Pearson JD: Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 1990; 75:688-695
38. Tannenbaum SH, Gralnick HR: γ-Interferon modulates von Willebrand factor release by cultured human endothelial cells. Blood 1990; 75:2177-2184
39. Suffrendini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
40. Gralnick HR, McKewon LP, Wilson OM, et al: Von Willebrand factor release induced by endotoxin. J Lab Clin Med 1989; 113:118-122
41. Van Deventer SJH, Buller HR, ten Cate JW, et al: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76:2520-2526
42. Van der Poll T, van Deventer SJH, Pasterkamp G, et al: Tumor necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemostas 1992; 67:623-626
43. Bone RC: Sepsis and its complications: the clinical problem. Crit Care Med 1994; 22(Suppl):S8-S11
44. Munro MJ, Pober JS, Cotran RS: Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989, 135:121-133
45. Harlan JM, Harker LA, Striker GF, et al: Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res 1983; 29:15-26
46. Paleolog EM, Carew MA, Pearson JD: Effects of tumor necrosis factor and interleukin-1 on von Willebrand factor secretion from human vascular endothelial cells. Int J Radiat Biol 1991; 60:279-285
47. Paleolog EM, Crossman DC, McVey JH, et al: Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 1990; 75:688-695
48. Mazzone D, Fichera A, Pratico G, et al: Factor VIII activity and von Willebrand factor in infants with viral bronchitis. N Engl J Med 1984; 311:1257-1258
49. Sabharwal AK, Bajaj SP, Ameri A, et al: Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Resp in Crit Care Med 1995; 151:758-767
50. Moss M, Ackerson L, Gillespie MK, et al: von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:15-20
51. Renard N, Nooijen PTGA, Schalkwijk L, et al: vWf release and platelet aggregation in human melanoma after perfusion with TNFα. J Pathol 1995; 176:279-287